CISD1 and cancer: Another study showed that the ferroptosis-related gene CISD1 is anticipated to become one of the novel biomarkers for predicting the prognosis of breast cancer patients, thereby providing a new target for cancer therapy (Wang D. et al., 2021) (Figure 2).